Literature DB >> 17132106

Detailed analysis of MIA protein by mutagenesis.

Raphael Stoll1, Sibylla Lodermeyer, Anja-Katrin Bosserhoff.   

Abstract

MIA (melanoma inhibitory activity) has been identified as a small protein secreted by malignant melanoma cells that interacts with extracellular matrix proteins including fibronectin. These findings suggest that MIA may play a role in tumor progression and the spread of malignant melanomas by mediating detachment of cells from extracellular matrix molecules. Here, we present a detailed study on functionally important MIA domains. Using site-directed mutagenesis, amino acids important for MIA structure and/or function were determined. Amino acids conserved in SH3 domains were shown to be important for structural integrity. In addition, amino acid residues necessary for MIA function were identified. Interestingly, not all of them are conserved with respect to other members of the MIA protein family. In summary, our results lead to a better understanding of MIA function. Regulating MIA functions in vivo may provide a novel therapeutic strategy for metastatic melanoma disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17132106     DOI: 10.1515/BC.2006.199

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  5 in total

1.  Role of Amino Acid Transporter SNAT1/SLC38A1 in Human Melanoma.

Authors:  Ines Böhme-Schäfer; Sandra Lörentz; Anja Katrin Bosserhoff
Journal:  Cancers (Basel)       Date:  2022-04-26       Impact factor: 6.575

2.  Human melanoma inhibitory protein binds to the FN12-14 Hep II domain of fibronectin.

Authors:  King Tuo Yip; Xueyin Zhong; Nadia Seibel; Oliver Arnolds; Miriam Schöpel; Raphael Stoll
Journal:  Biointerphases       Date:  2017-05-31       Impact factor: 2.456

3.  Modulation of cartilage differentiation by melanoma inhibiting activity/cartilage-derived retinoic acid-sensitive protein (MIA/CD-RAP).

Authors:  Thomas Schubert; Jacqueline Schlegel; Rainer Schmid; Alfred Opolka; Susanne Grassel; Martin Humphries; Anja-Katrin Bosserhoff
Journal:  Exp Mol Med       Date:  2010-03-31       Impact factor: 8.718

4.  Targeting melanoma metastasis and immunosuppression with a new mode of melanoma inhibitory activity (MIA) protein inhibition.

Authors:  Jennifer Schmidt; Alexander Riechers; Raphael Stoll; Thomas Amann; Florian Fink; Thilo Spruss; Wolfram Gronwald; Burkhard König; Claus Hellerbrand; Anja Katrin Bosserhoff
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

5.  Small Molecules Antagonise the MIA-Fibronectin Interaction in Malignant Melanoma.

Authors:  King Tuo Yip; Xue Yin Zhong; Nadia Seibel; Stefanie Pütz; Jasmin Autzen; Raphael Gasper; Eckhard Hofmann; Jürgen Scherkenbeck; Raphael Stoll
Journal:  Sci Rep       Date:  2016-05-06       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.